SEARCH

SEARCH BY CITATION

References

  • Ambudkar, S.V., Dey, S., Hrycyna, C.A., Ramachandra, M., Pastan, I., Gottesman, M.M. (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annual Review of Pharmacology and Toxicology, 39, 361398.
  • Barg, S., Renström, E., Berggren, P.O., Bertorello, A., Bokvist, K., Braun, M., Eliasson, L., Holmes, W.E., Köhler, M., Rorsman, P., Thévenod, F. (1999) The stimulatory action of tolbutamide on Ca2+-dependent exocytosis in pancreatic beta cells is mediated by a 65-kDa mdr-like P-glycoprotein. Proceedings of the National Academy of Sciences of the United States of America, 96, 55395544.
  • Chaudhary, P.M. & Roninson, I.B. (1991) Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell, 66, 8594.
  • Chaudhary, P.M., Mechetner, E.B., Roninson, I.B. (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood, 80, 27352739.
  • Chong, A.S., Markham, P.N., Gebel, H.M., Bines, S.D., Coon, J.S. (1993) Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunology and Immunotherapy, 36, 133139.
  • Cianfriglia, M., Willingham, M.C., Tonbesi, M., Scagliotti, G.V., Frasca, F., Chersi, A. (1994) P-glycoprotein epitope mapping. I. Identification of a linear human-specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug-resistant cells. International Journal of Cancer, 56, 153164.
  • Davey, M.W., Hargrave, R.M., Davey, R.A. (1996) Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells. Leukemia Research, 20, 657664. DOI: 10.1016/0145-2126(96)00023-9
  • Drach, D., Zhao, S., Drach, J., Mahadevia, R., Gattringer, C., Huber, H., Andreeff, M. (1992) Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood, 80, 27292734.
  • Egashira, M., Kawamata, N., Sugimoto, K., Kaneko, T., Oshimi, K. (1999) P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood, 93, 599606.
  • Georges, E., Bradley, G., Gariepy, J., Ling, V. (1990) Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America, 87, 152156.
  • Georges, E., Tsuruo, T., Ling, V. (1993) Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody. Journal of Biological Chemistry, 268, 17921798.
  • Germann, U.A., Ford, P.J., Shlyakhter, D., Mason, V.S., Harding, M.W. (1997) Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP. Anticancer Drugs, 8, 141155.
  • Gottesman, M.M. & Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Review of Biochemistry, 62, 385427.
  • Gupta, S., Kim, C.H., Tsuruo, T., Gollapudi, S. (1992) Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function. Journal of Clinical Immunology, 12, 451458.
  • Hollo, Z., Homolya, L., Hegedus, T., Sarkadi, B. (1996) Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells. FEBS Letters, 383, 99104.DOI: 10.1016/0014-5793(96)00237-2
  • Homolya, L., Hollo, Z., Germann, U.A., Pastan, I., Gottesman, M.M., Sarkadi, B. (1993) Fluorescent cellular indicators are extruded by the multidrug resistance protein. Journal of Biological Chemistry, 268, 2149321496.
  • Kawai, K., Kusano, I., Ido, M., Sakurai, M., Shiraishi, T., Yatani, R. (1994) Identification of a P-glycoprotein-related protein (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells. Biochemical and Biochemical Research Communications, 198, 804810.
  • Klimecki, W.T., Futscher, B.W., Grogan, T.M., Dalton, W.S. (1994) P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood, 83, 24512458.
  • Klimecki, W.T., Taylor, C.W., Dalton, W.S. (1995) Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporine A analogs. Journal of Clinical Immunology, 15, 152158.
  • Kobayashi, Y., Yamashiro, T., Nagatake, H., Yamamoto, T., Watanabe, N., Tanaka, H., Shigenobu, K., Tsuruo, T. (1994) Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52. Biochemical Pharmacology, 48, 16411646.
  • Lecureur, V., Sun, D., Hargrove, P., Schuetz, E.G., Kim, R.B., Lan, L.B., Schuetz, J.D. (2000) Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. Molecular Pharmacology, 57, 2435.
  • Litman, T., Brangi, M., Hudson, E., Fetsch, P., Abati, A., Ross, D.D., Miyake, K., Resau, J.H., Bates, S.E. (2000) The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). Journal of Cell Science, 113, 20112021.
  • Ma, J.F., Grant, G., Staelens, B., Howard, D.L., Melera, P.W. (1999) In vitro translation of a 2.3-kb splicing variant of the hamster pgp1 gene whose presence in transfectants is associated with decreased drug resistance. Cancer Chemotherapy and Pharmacology, 43, 1928.DOI: 10.1007/s002800050858
  • Markham, P.N., Coon, J.S., Chong, A.S., Gebel, H.M. (1993) Natural killer cell cytotoxicity and the multidrug resistance gene. Transplantation Proceedings, 25, 9697.
  • Neyfakh, A.A. (1988) Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Experimental Cell Research, 174, 168176.
  • Rao, V.V., Anthony, D.C., Piwnica-Worms, D. (1994) MDR1 gene-specific monoclonal antibody C494 cross-reacts with pyruvate carboxylase. Cancer Research, 54, 15361541.
  • Rao, V.V., Anthony, D.C., Piwnica-Worms, D. (1995) Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase. Journal of Histochemistry and Cytochemistry, 43, 11871192.
  • Robey, R., Bakke, S., Stein, W., Meadows, B., Litman, T., Patil, S., Smith, T., Fojo, T., Bates, S. (1999) Efflux of rhodamine from CD56+ cells as a surrogate marker for reversal of P-glycoprotein-mediated drug efflux by PSC 833. Blood, 93, 306314.
  • Schinkel, A.H. (1998) Pharmacological insights from P-glycoprotein knockout mice. International Journal of Clinical Pharmacology and Therapeutics, 36, 913.
  • Schinkel, A.H., Smit, J.J., Van Tellingen, O., Beijnen, J.H., Wagenaar, E., Van Deemter, L., Mol, C.A., Van Der Valk, M.A., Robanus-Maandag, E.C., Te Riele, H.P. (1994) Disruption of the mouse MDR1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs. Cell, 77, 491502.
  • Sparreboom, A., Van Asperen, J., Mayer, U., Schinkel, A.H., Smit, J.W., Meijer, D.K., Borst, P., Nooijen, W.J., Beijnen, J.H., Van Tellingen, O. (1997) Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proceedings of the National Academy of Sciences of the United States of America, 94, 20312035.
  • Thévenod, F., Hildebrandt, J.P., Striessnig, J., De Jonge, H.R., Schulz, I. (1996) Chloride and potassium conductances of mouse pancreatic zymogen granules are inversely regulated by an approximately 80-kDa MDR1a gene product. Journal of Biological Chemistry, 271, 33003305.DOI: 10.1074/jbc.271.6.3300
  • Warren, H.S. & Skipsey, L.J. (1991) Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: the FcR gamma III (CD16) molecule and NK cell differentiation. Immunology, 72, 150157.
  • Wilisch, A., Noller, A., Handgretinger, R., Weger, S., Nüssler, V., Niethammer, D., Probst, H., Gekeler, V. (1993) MDR1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood. Cancer Letters, 69, 139148.
  • Yamashiro, T., Watanabe, N., Yokoyama, K.K., Koga, C., Tsuruo, T., Kobayashi, Y. (1998) Requirement of expression of P-glycoprotein on human natural killer leukemia cells for cell-mediated cytotoxicity. Biochemical Pharmacology, 55, 13851390.DOI: 10.1016/s0006-2952(97)00652-7